NASDAQ: ALNYAlnylam Pharmaceuticals Inc Stock Ownership - Who owns Alnylam Pharmaceuticals?
Insider buying vs selling
Have Alnylam Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Phillip A. Sharp | Director | 2024-02-29 | 101 | $154.07 | $15.56kSell |
| Phillip A. Sharp | Director | 2024-02-29 | 30,000 | $59.25 | $1.78MBuy |
| Phillip A. Sharp | Director | 2024-02-29 | 13,005 | $150.60 | $1.96MSell |
| Phillip A. Sharp | Director | 2024-02-29 | 13,557 | $151.43 | $2.05MSell |
| Phillip A. Sharp | Director | 2024-02-29 | 915 | $152.40 | $139.45kSell |
| Phillip A. Sharp | Director | 2024-02-29 | 1,906 | $153.62 | $292.80kSell |
| Phillip A. Sharp | Director | 2024-02-29 | 516 | $156.54 | $80.77kSell |
| Indrani Lall Franchini | EVP CLO Secretary | 2024-02-28 | 9 | $157.30 | $1.42kSell |
| Indrani Lall Franchini | EVP CLO Secretary | 2024-02-28 | 66 | $156.38 | $10.32kSell |
| Indrani Lall Franchini | EVP CLO Secretary | 2024-02-28 | 111 | $155.45 | $17.25kSell |
ALNY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ALNY insiders and whales buy or sell their stock.
ALNY Shareholders
What type of owners hold Alnylam Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ag Novartis | 11.70% | 14,800,620 | $2.17B | Insider |
| Capital World Investors | 10.11% | 12,789,236 | $1.88B | Institution |
| Vanguard Group Inc | 9.48% | 11,994,261 | $1.76B | Institution |
| Sanofi | 8.34% | 10,554,134 | $1.55B | Insider |
| Fmr LLC | 7.88% | 9,967,996 | $1.46B | Institution |
| Blackrock Inc | 7.13% | 9,025,007 | $1.33B | Institution |
| Wellington Management Group LLP | 5.70% | 7,209,005 | $1.06B | Institution |
| Baillie Gifford Co | 5.24% | 6,623,577 | $973.20M | Institution |
| Dodge Cox | 3.01% | 3,811,480 | $560.02M | Institution |
| Price T Rowe Associates Inc | 2.91% | 3,685,753 | $541.55M | Institution |
ALNY vs Biotech Stocks
Alnylam Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.